ID: ALA106585

Max Phase: Preclinical

Molecular Formula: C17H18O3

Molecular Weight: 270.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)CCCCc1ccc(Oc2ccccc2)cc1

Standard InChI:  InChI=1S/C17H18O3/c18-17(19)9-5-4-6-14-10-12-16(13-11-14)20-15-7-2-1-3-8-15/h1-3,7-8,10-13H,4-6,9H2,(H,18,19)

Standard InChI Key:  OIMJIOIOIVCZPF-UHFFFAOYSA-N

Associated Targets(non-human)

Human papillomavirus regulatory protein E2 38 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 270.33Molecular Weight (Monoisotopic): 270.1256AlogP: 4.28#Rotatable Bonds: 7
Polar Surface Area: 46.53Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.33CX Basic pKa: CX LogP: 4.44CX LogD: 1.50
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.76Np Likeness Score: -0.02

References

1. Hajduk PJ, Dinges J, Miknis GF, Merlock M, Middleton T, Kempf DJ, Egan DA, Walter KA, Robins TS, Shuker SB, Holzman TF, Fesik SW..  (1997)  NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein.,  40  (20): [PMID:9379433] [10.1021/jm9703404]

Source